Cite
MLA Citation
H. Li et al.. “Very Low-Dose Decitabine is Effective in Treating Intermediate or High Risk Myelodysplastic Syndrome.” Leukemia research, vol. 55, n.d., pp. S65–S66. http://access.bl.uk/ark:/81055/vdc_100045920464.0x00002d
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
H. Li et al.. “Very Low-Dose Decitabine is Effective in Treating Intermediate or High Risk Myelodysplastic Syndrome.” Leukemia research, vol. 55, n.d., pp. S65–S66. http://access.bl.uk/ark:/81055/vdc_100045920464.0x00002d